General Question

eas78's avatar

Suppose that experience has shown that only one-third of all patients having a particular disease will recover if given the standard treatment. A new drug is to be tested on a group of 12 volunteers. It is believed that the new drug will increase the individual recovery rate to one-half.

Asked by eas78 (1points) March 9th, 2008

If health regulations require that at least 7 of the 12 patients should recover before the new drug can be licensed, what is the probability the new drug will be discredited even with the increase in recovery rate?

Observing members: 0 Composing members: 0

5 Answers

delirium's avatar

…..<.< We’re not doing your homework.

bpeoples's avatar

Might want to ask some more specific questions about the statistical model you think might work.

But yeah, not doing your homework.

The answer is not 73%.

Lightlyseared's avatar

100% possibilty that the new drug will be discredited due to the small sample size, no control, no randomisation or random allocation and no blinding of either patients or investigators.

Cardinal's avatar

Testing numbers should be in the tens or hundreds of thousands. Now you must have (99%) of the time a blind study as a control.

bpeoples's avatar

Ah, but the problem is that you can follow this small (12-person) trial up with a larger one that might show that the effect is real, rather than an anomaly.

Answer this question

Login

or

Join

to answer.

This question is in the General Section. Responses must be helpful and on-topic.

Your answer will be saved while you login or join.

Have a question? Ask Fluther!

What do you know more about?
or
Knowledge Networking @ Fluther